| Region | # |
|---|---|
| AS - Asia, other | 14 |
| NA - North America | 11 |
| Unknown | 1 |
| Total | 26 |
| Country | # |
|---|---|
| CN - China | 13 |
| US - United States of America | 11 |
| TW - Taiwan | 1 |
| Unknown | 1 |
| Total | 26 |
| City | # |
|---|---|
| Shanghai | 3 |
| Xinxiang | 3 |
| Zhengzhou | 2 |
| Beijing | 1 |
| Chongqing | 1 |
| Des Moines | 1 |
| Qingping | 1 |
| San Jose | 1 |
| Songyang | 1 |
| Taipei | 1 |
| other | 11 |
| Total | 26 |
| Most viewed items | # |
|---|---|
| ID: 191661 - Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients | 26 |
| Total | 26 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| 2020 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 5 | 0 | 0 | 9 |
| 2021 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2022 | 0 | 1 | 0 | 3 | 2 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 13 |
| 2023 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Ever | 26 | ||||||||||||
